// App-Quantinova.ai

1221 : Dopaminergic medication improves movement vigour in Parkinson’s but not the adaptation of movement speed to curvature

Researchers

Presenter

  • L. Hickman

Principal Investigators

  • D. Fraser

  • J. Galea

  • J. Cook

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Parkinson's disease

Biomarkers

  • N/A

Drug/Treatment

  • Dopamine hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved